Annual SG&A
$253.01M$5.64M+2.28%
Summary
- Current Value
- As of today, GSK annual SG&A is $253.01M, up +2.28% on
- Historical Performance
- GSK annual SG&A is up +8.85% over the past 3 years, and down -49.54% over the past 5 years
- All-Time High Comparison
- GSK annual SG&A is currently -98.74% below its historical high of $20.15B set on
- 3-Year Low Comparison
- GSK annual SG&A is +6.98% above its 3-year low of $236.50M reached on an earlier date
- Sector Comparison
- GSK annual SG&A is higher than 90.93% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $253.01M | +2.3% | +8.8% | -49.5% | -98.3% | |
| Quarterly SG&A | $3.02B | -38.9% | +24.9% | -12.4% | -5.1% | |
| TTM SG&A | $46.02B | +228.3% | +342.8% | +207.5% | +156.8% | |
| Price | $48.22 | +44.2% | +36.3% | +24.4% | +27.6% | |
| Annual Operating Expenses | $23.40B | +30.4% | +45.9% | +17.5% | +18.9% | |
| Annual Operating Profit | $5.14B | -43.8% | -23.4% | -36.0% | -61.1% | |
| Annual D&A | $3.26B | +14.3% | +11.7% | +9.5% | +33.0% | |
| Annual Revenue | $40.09B | +6.3% | +18.0% | -6.9% | -9.9% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $253.01M | at high | |
| 5Y | $523.20M | N/A | -51.6% |
| All | $20.15B | -98.7% |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $236.50M | N/A | +7.0% |
| 5Y | $232.43M | +8.8% | |
| All | $0.00 | N/A |
SG&A History
FAQ
What is the current annual SG&A of GSK?
As of today, GSK annual SG&A is $253.01M
What is 1-year change in GSK annual SG&A?
GSK annual SG&A is up +2.28% year-over-year
What is 3-year change in GSK annual SG&A?
GSK annual SG&A is up +8.85% over the past 3 years
How far is GSK annual SG&A from its all-time high?
GSK annual SG&A is currently -98.74% below its historical high of $20.15B set on December 31, 2010
How does GSK annual SG&A rank versus sector peers?
GSK annual SG&A is higher than 90.93% of companies in Healthcare sector
When is GSK next annual earnings release?
The next annual earnings release for GSK is on
Quarterly SG&A
$3.02B$160.44M+5.61%
Summary
- Current Value
- As of today, GSK quarterly SG&A is $3.02B, up +5.61% on
- Historical Performance
- GSK quarterly SG&A is down -38.89% year-over-year, and up +24.90% over the past 3 years
- All-Time High Comparison
- GSK quarterly SG&A is currently -57.00% below its historical high of $7.02B set on
- 3-Year Low Comparison
- GSK quarterly SG&A is +15.94% above its 3-year low of $2.60B reached on
- Sector Comparison
- GSK quarterly SG&A is higher than 99.55% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $3.02B | +5.6% | -38.9% | +24.9% | -12.4% | |
| Annual SG&A | $253.01M | – | +2.3% | +8.8% | -49.5% | |
| TTM SG&A | $46.02B | +233.1% | +228.3% | +342.8% | +207.5% | |
| Price | $48.22 | +9.3% | +44.2% | +36.3% | +24.4% | |
| Quarterly Operating Expenses | $5.04B | -8.2% | -25.6% | +29.4% | +7.3% | |
| Quarterly Operating Profit | $3.47B | +51.4% | +460.2% | +40.0% | +17.3% | |
| Quarterly D&A | $1.05B | -31.4% | -13.6% | -8.8% | +29.6% | |
| Quarterly Revenue | $11.52B | +8.0% | +10.6% | +25.2% | +3.2% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.41B | N/A | -11.5% |
| 3Y | $4.94B | -38.9% | |
| 5Y | $4.94B | -38.9% | |
| All | $7.02B | -57.0% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.61B | +15.8% | |
| 3Y | $2.60B | +15.9% | |
| 5Y | $2.31B | +30.5% | |
| All | $0.00 | N/A |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of GSK?
As of today, GSK quarterly SG&A is $3.02B
What is GSK quarterly SG&A most recent change?
GSK quarterly SG&A was up +5.61% on September 1, 2025
What is 1-year change in GSK quarterly SG&A?
GSK quarterly SG&A is down -38.89% year-over-year
How far is GSK quarterly SG&A from its all-time high?
GSK quarterly SG&A is currently -57.00% below its historical high of $7.02B set on December 31, 2010
How does GSK quarterly SG&A rank versus sector peers?
GSK quarterly SG&A is higher than 99.55% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
TTM SG&A
$46.02B$2.50B+5.75%
Summary
- Current Value
- As of today, GSK TTM SG&A is $46.02B, up +5.75% on
- Historical Performance
- GSK TTM SG&A is up +228.31% year-over-year, and up +342.80% over the past 3 years
- All-Time High Comparison
- GSK TTM SG&A is currently -23.79% below its historical high of $60.39B set on an earlier date
- 3-Year Low Comparison
- GSK TTM SG&A is +80.37% above its 3-year low of $25.52B reached on an earlier date
- Sector Comparison
- GSK TTM SG&A is higher than 97.53% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | $46.02B | +233.1% | +228.3% | +342.8% | +207.5% | |
| Annual SG&A | $253.01M | – | +2.3% | +8.8% | -49.5% | |
| Quarterly SG&A | $3.02B | +5.6% | -38.9% | +24.9% | -12.4% | |
| Price | $48.22 | +9.3% | +44.2% | +36.3% | +24.4% | |
| TTM Operating Profit | $9.88B | +40.5% | +36.3% | +26.7% | +9.0% | |
| TTM D&A | $4.75B | -3.4% | +14.6% | +45.0% | +850.7% | |
| TTM Revenue | $42.06B | +2.7% | +6.0% | +13.4% | -3.7% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $46.02B | N/A | at high |
| 3Y | $46.02B | N/A | at high |
| 5Y | $46.02B | N/A | at high |
| All | $60.39B | N/A | -23.8% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $41.62B | N/A | +10.6% |
| 3Y | $25.52B | N/A | +80.4% |
| 5Y | $25.52B | N/A | +80.4% |
| All | -$29.95B | N/A | +253.7% |
TTM SG&A History
FAQ
What is the current TTM SG&A of GSK?
As of today, GSK TTM SG&A is $46.02B
What is GSK TTM SG&A most recent change?
GSK TTM SG&A was up +5.75% on September 1, 2025
What is 1-year change in GSK TTM SG&A?
GSK TTM SG&A is up +228.31% year-over-year
How does GSK TTM SG&A rank versus sector peers?
GSK TTM SG&A is higher than 97.53% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
Selling, General & Administrative Expenses Formula
SG&A = Operating Expenses − Cost Of Goods Sold − R&D
Data Sources & References
- GSK Official Website www.gsk.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1131399/000113139925000007/0001131399-25-000007-index.htm
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk